4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005233
Chief Scientific Officer sold 23,370 shares at an average $66.82 ($1,561,592)
- Chief Scientific Officer acquired 23,370 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-21 | Option exercise | +23,370 | $6.32 | $147,698 | 24,049 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-21 | Sale | −3,941 | $66.06 | $260,342 | 20,108 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-21 | Sale | −17,329 | $66.90 | $1,159,310 | 2,779 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-21 | Sale | −2,100 | $67.59 | $141,939 | 679 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-21 | Option exercise · Stock Option (Right to Buy) | −23,370 | 210,330 | D | ||
| Open-market sales · 23,370 sh · avg $66.82 · $1,561,592 | |||||||
Loading xslF345X03/doc4.xml…